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THE MEASLES & RUBELLA INITIATIVE 
GLOBAL AND FIELD BRANDING GUIDELINES (JUNE 2013) 
 
 
SUMMARY: The Measles & Rubella Initiative is a global partnership that supports countries to implement the 
Global Measles & Rubella Strategic Plan 2012-2020, including funding and technical support for supplementary 
immunization activities. These guidelines aim to help the M&R Initiative partners including countries to use the 
correct Initiative name, acknowledge the Initiative and its partners, use its logo correctly, and offer artwork that 
can be used to promote immunization. 
PURPOSE OF THIS DOCUMENT: This document aims to provide branding and acknowledgement guidelines, 
together with design elements and artworks that can be used by all partners including Governments working with 
or supported by the Measles & Rubella Initiative. High resolution design elements are available in a separate file 
titled The Measles & Rubella Initiative - Brand Assets. This file should accompany this document, or can be 
requested from MeaslesRubellaInitiative@gmail.com.
WHAT IS THE MEASLES & RUBELLA INITIATIVE? The Measles & Rubella Initiative (M&R Initiative) is a 
global partnership committed to ensuring no child dies from measles or is born with congenital rubella syndrome. 
Founded originally as the Measles Initiative in 2001, it’s led by the American Red Cross, the United Nations Founda-
tion, the U.S. Centers for Disease Control and Prevention, UNICEF and the World Health Organization. 
Since 2001 the Initiative has supported 80 countries to deliver more than 1.1 billion doses of measles vaccine, 
helped to raise measles vaccination coverage to 84% globally, and reduced measles deaths by 71%. These efforts 
have contributed significantly to reduction in child mortality as per Millennium Development Goal 4. From 2012, 
the Initiative is combining measles with rubella control and elimination efforts and supports a new 2012-2020 
Global Measles & Rubella Strategic Plan. 
The Measles & Rubella Initiative works with countries to provide technical and financial support to improve routine 
immunization, conduct successful measles and rubella campaigns and strengthen surveillance and laboratory 
networks. The Initiative aims to reduce measles mortality by 95% by 2015 and eliminate measles and 
rubella in at least five of six World Health Organization regions by 2020. 
Key supporters of the Measles & Rubella Initiative include countries and governments affected by measles, rubella 
and congenital rubella syndrome; the chapters of the American Red Cross; Anne Ray Charitable Trust; American 
Academy of Pediatrics; BD; the Bill and Melinda Gates Foundation; the Canadian International Development Agency 
(CIDA); the Church of Jesus Christ of Latter-day Saints; the GAVI Alliance; Global Payments, Inc.; Herman and Katherine 
Peters Foundation; International Federation of Pharmaceutical Manufacturers Association; International Federation of 
Red Cross and Red Crescent Societies; the International Pediatric Association; Izumi Foundation; Jeppesen; the Lions 
Clubs International Foundation; Japanese Agency for Development Cooperation (JICA); Merck Co. Foundation; the 
Norwegian Ministry of Foreign Affairs, ONE Campaign; the Rockefeller Foundation; Sabin Vaccine Institute; the Task 
Force for Global Health; United Kingdom Department for International Development; the Vodafone Foundation; the 
World Bank and the WNBA. The Measles & Rubella Initiative is also grateful to its many individual private donors.
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REFERENCING THE MEASLES & RUBELLA INITIATIVE 
HOW SHOULD THE MEASLES & RUBELLA INITIATIVE BE REFERENCED? The Measles & Rubella 
Initiative was “the Measles Initiative” until April 2012 at which point it announced its name change, in keeping with 
the new global strategy aimed at eliminating measles, rubella and congenital rubella syndrome. 
In the first instance in a text the Measles & Rubella Initiative should be referred to by its full name. In the second, 
it may be referred to as the “M&R Initiative”. A reference within the same paragraph or in a document where the 
meaning is clear may refer to “the Initiative”.  
 
PLEASE DO
 Refer to the “Measles & Rubella Initiative” rather 
than “The Measles Initiative” from April 2012  
 Replace any evergreen references to “the Mea-
sles Initiative” on your website, boilerplates or 
other partnership documents with the Measles 
& Rubella Initiative   
PLEASE DO NOT
 Refer to the Measles & Rubella Initiative as 
“MRI” given the possible confusion with “mag-
netic resonance imaging”
 Change dated historical references to “The Mea-
sles Initiative” in documents published before 
April 2012 (eg. in news releases)  
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THE MEASLES & RUBELLA INITIATIVE LOGO
There are two main forms of the logo:  There are color variations on each of these including a full color, a black 
version, a reverse, and a reverse with 50% grey dots.  For more information about usage please see the accompa-
nying “logo specification” guidance. 
1  The first references the Measles & Rubella  
Initiative accompanied by three red dots de-
scending and shrinking on the left-hand side. 
These dots represent the elimination of measles 
and rubella. Partners in the field will mainly use 
this version of the logo. 
2  The second is the logo with the tag line “a 
global partnership to stop measles & rubella”.  
This version will mainly be used by the M&R 
Initiative partnership. 
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THE MEASLES & RUBELLA INITIATIVE MESSAGES
The Measles & Rubella Initiative has developed a set of messages aimed to capture the urgency, progress,  
possibility and imperative to attain the measles, rubella and immunization goals.  
The main message is: "Measles Moves Fast." and "Measles and Rubella Move Fast."   
This phrase is paired with the following action messages: 
- We have committed to move faster.         - We must move faster.         - We know how to move faster.     
- We can afford to move faster.                   - Together, we move faster. 
These phrases should be set in Vectora Bold, all caps, with 80pt tracking, and can be used within the M&RI arrows 
like this on a white background:
MEASLES MOVES FAST
WE MUST MOVE FASTER
MEASLES AND RUBELLA MOVE FAST
WE HAVE COMMITTED TO MOVE FASTER
MEASLES MOVES FAST
TOGETHER, WE MOVE FASTER
And like this on a colored background:
GRAPHIC FILE NAME: MandRI.Arrows.eps
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PLACEMENT, SIZING AND SHAPE
If you are using the logo, please bear the following in mind:  
•	 The	logo	should	be	printed	the	same	size	as	other	 
contributing partners 
•	 If	printed	with	the	logos	of	the	founding	partners	it	
should appear before them  
•	 If	printed	with	other	logos	(government	&	other	partners),	
it should be printed in the order deemed appropriate 
by the responsible committee  (social mobilization or 
equivalent) 
•	 If	printing	on	a	dark	or	busy	background,	use	the	reverse	
white logo 
•	 Maintain	adequate	space	around	the	logo	to	ensure	 
legibility 
PLEASE DO NOT
 Alter the color of the logo
 Pull the logo into different shapes or alter the width/
length ratio
 Print the logo smaller than 18 mms in width  
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HOW SHOULD THE MEASLES & RUBELLA INITIATIVE 
BE ACKNOWLEDGED IN COUNTRY IMMUNIZATION 
ACTIVITIES? 
Decisions about how to acknowledge partners, what logos to use and in what order are usually made at national 
level by the social mobilization committee or its equivalent.   
When the M&R Initiative has supported the activity (whether a supplementary campaign or other activity), 
materials associated with the activity should include acknowledgement of the Initiative. Where logos are used 
this should include use of the logo.  Generally speaking, WHO and UNICEF will be able to confirm if the origin of 
funding or technical support is from the M&R Initiative, whose funding is commonly channeled through the UN 
Foundation.
Written acknowledgement of the M&R Initiative should be evident in documents including news releases  
describing or reporting on the activity. Here is sample language for written materials including news releases:  
Short: “Funding and technical assistance for this campaign has been provided by the Measles & Rubella Initiative.“
Longer: “Funding and technical assistance for this campaign has been provided by the Measles & Rubella Initia-
tive, a global partnership committed to ensuring no child dies from measles or is born with congenital rubella 
syndrome. The Initiative is led by the American Red Cross, the United Nations Foundation, the U.S. Centers for 
Disease Control and Prevention, UNICEF and the World Health Organization.  Since 2001 the Initiative has sup-
ported 80 countries to deliver more than 1.1 billion doses of measles vaccine, helped to raise measles vaccination 
coverage to 84% globally, and reduced measles deaths by 71%. 
The logo should be used on information, education and communication (IEC) and other printed materials including 
banners, leaflets, brochures and in materials destined for the media.  
SHOULD A COUNTRY ACKNOWLEDGE WHO AND UNICEF IN ADDITION TO THE MEASLES  
& RUBELLA INITIATIVE DURING COUNTRY ACTIVITIES? The American Red Cross, the Centers for 
Disease Control, the UN Foundation, UNICEF and the World Health Organization are founding partners of the 
Initiative. If the Initiative has supported the activity it should be acknowledged. Other founding partners should 
decide with the social mobilization committee (or equivalent) on additional acknowledgement.   
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HOW SHOULD OTHER M&R INITIATIVE PARTNERS BE ACKNOWLEDGED IN COUNTRY  
IMMUNIZATION ACTIVITIES? 
It is good practice to acknowledge partners who have provided support to measles & rubella immunization activi-
ties. This includes M&R Initiative partners such as the GAVI Alliance, the International Red Cross, the Lions Clubs 
and the Church of LDS if they are involved. Their organization names and logos should be added to materials in 
consultation with the national office.  
Example of logo placement on printed materials including banners: 
SUMMARY POLICIES 
The Measles & Rubella Initiative founding partners have the following policies for use of their logos on products 
linked to measles and rubella activities: 
Red Cross: Logo use requires agreement nationally. Contact the national Red Cross/ Red Crescent society.  
CDC:  Logo use requires permission from CDC HQ. Contact Alan Janssenn:  axj3@cdc.gov. Note that  
  acquiring such permission may take several weeks. 
UNICEF:   Logo use requires agreement nationally. Contact the national UNICEF office. 
UNF:  Logo use requires permission from UNF HQ. Contact Andrea Gay: agay@unfoundation.org or  
  Eric Porterfield: eporterfield@unfoundation.org.  
WHO:  Logo use requires agreement nationally. Contact the national WHO office. 
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WHO Logo Unicef Logo
Government 
Logo
Lions Logo Natl RC LDS
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MEASLES & RUBELLA INITIATIVE  
TYPOGRAPHY AND COLOR PALETTE 
The Measles & Rubella Initiative has created an overall branded look and feel, that incorporates specific typefaces 
and colors. The Initiative is also honored to be working with acclaimed illustrator Sophie Blackall, who is providing 
beautiful artworks for our collective use. When using these artworks, they may be paired with a Sophie Blackall 
style typeface as explained below.  
MEASLES & RUBELLA INITIATIVE TYPEFACES
VECTORA ROMAN, BOLD, BLACK
Set in ALL CAPS, this font to be used as main titling typeface for Measles & Rubella Initiative materials.  
Use of all caps, kerned out 60-100 is recommended for headers. Vectora is available for purchase on  
http://www.myfonts.com/fonts/linotype/vectora/ If you don’t already have the Vectora font, and are  
not in a position to purchase it, you may use Arial Roman, Bold, Black as an alternative.
 
Vectora Light and Roman
Set in upper/lower case, this font to be used as body text for longer blocks of text. If a web-safe font option is 
required, please use Arial Light or Roman.
Sophie Blackall Regular and Alternates
A secondary font based on the handlettering of Measles & Rubella Initiative Artist Sophie Blackall. This font can be 
used together with Sophie’s artwork used in exhibits and consumer goods (…) and not in technical documents.
This font is available for download and use as part of The Measles and Rubella Initiative - Brand Assets package.
 
MEASLES & RUBELLA INITIATIVE COLOR PALETTE
CORE COLORS:
SECONDARY COLORS:
C100 M90 Y0 K20 / R196 G20 B37 C84 M47 Y36 K10 / R48 G110 B133 C38 M8 Y65 K0 / R165 G196 B126 C20 M5 Y5 K0 / R201 G222 B232
C100 M90 Y0 K0 / R237 G27 B47 C20 M10 Y100 K0 / R213 G205 B39 C0 M47 Y93 K0 / R247 G152 B42 C10 M0 Y30 K0 / R231 G239 B193
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MEASLES & RUBELLA INITIATIVE  
DESIGN ELEMENTS AND PATTERNS
SPOT MOTIF
The spot or dot is the core visual motif for the Measles & Rubella Initiative. When placing photographs or creating 
graphic elements for print or web applications, circular picture boxes are ideal to tie back to the logo.  
Photographs and artwork can be placed in circular picture boxes as full-color images. Photographs can also be 
placed as monochrome or duotone:
 
DISAPPEARING DOT MOTIF
The disappearing dot can be used as an ornament, an embellishment to artwork and/or photographs, or as the basis 
of a pattern. Any color from the palette can be applied to the painted dot/spot as needed. See specifics re: tints 
below. The largest dot in the motif can hold a photograph, but there should be no more than one photograph used 
in each instance the motif appears. The motif can be rotated or scaled as needed to work in each instance, but the 
proportions and spacing of the dots should not be adjusted.
 
30% TINT
60% TINT
100% TINT
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PAINTED DOT ARTWORK/PATTERNS
The more organic-edged painted dot can be used as a bullet, design motif, or as the basis of a pattern (see ex-
amples of repeat patterns below). The preferred color for the painted dots is one of the two reds from the color 
palette, but can be colored in any of the colors from the official palette. 
OTHER PATTERNS
These patterns can be used as backgrounds to add interest/texture to designs. The paintedbackground.tif file can 
be used instead of a solid color background - if a more organic/hand-done color is desired.
painteddotzigzag.tif painteddotgrid.tif painteddotdiamonds.tif
diagonallines.tif disappearingdots.tif paintedbackground.tif
painteddots.tif
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DUAL ARROW MOTIF
This motif is meant to illustrate the idea that ‘Measles is fast - we must move faster’. This motif is 
useful to bring energy to type-heavy pages, and to call attention to important headers, etc. Arrows 
can be placed horizontally, pointing left or right, and can be placed vertically, pointing up or down. 
On a colored background, the larger (faster) arrow should appear white. On a white background, 
the larger/faster arrow should appear in light blue or light green. Arrows can be scaled as needed 
for each project. 
ICONIC PERSON
This graphic/icon should be used only in context of infographics/maps/in small scale. The Iconic 
person can be colored in any of the colors from the palette. 
MeaslesandRubella.arrows.eps
MeaslesandRubella.iconicperson.eps
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MEASLES & RUBELLA INITIATIVE  
SOPHIE BLACKALL ART ASSETS
 
Sophie Blackall is a renowned, award-winning illustrator who is a champion for the Measles & Rubella Initiative. 
She has travelled to countries, including the Democratic Republic of the Congo and India to witness immuniza-
tion activities and talk to health workers and families. These trips have resulted in a collection of beautiful artwork 
which M&R Initiative partners may use, and forms the basis for much of the Initiative’s branding. 
The artwork includes a full exhibit illustrating a measles campaign, individual children who are “stopping” measles, 
and some stand-alone paintings. Some of the work has been designed into products including note cards, posters, 
and presentation templates.  M&R Initiative partners are encouraged to use these. 
The artworks can be used in many ways. Some ideas:  
•	 Display the “Let Every Child Have a Name” exhibit at partner or fundraising events, or in government or  
organization buildings 
•	 Print the panels as posters to use in health posts for IEC and social mobilization 
•	 Print and frame individual pieces to offer as gifts to stakeholders
•	 Print the artworks on communication products such as greeting cards, calendars, t-shirts, mugs or bags for 
fundraising or to offer as gifts  
•	 Use the art to illustrate your presentations, manuals or other literature 
Some guidelines: 
•	 The work should be used to promote immunization against measles and rubella, and other vaccine prevent-
able diseases whether in routine immunization or campaigns.  
•	 The artworks should be credited to Sophie Blackall, courtesy of the Measles & Rubella Initiative. 
•	 Artwork should be printed by high-quality printers using accurate colors. Individual pieces for display can be 
mounted on foam core or framed.  
•	 The “Let Every Child Have a Name” exhibit was designed for printing in size 30”x40” (76 x 101 cms). It can be 
scaled up or down in size provided the proportions are maintained. If the proportions are not maintained, the 
artwork will be distorted.
•	 In general, all printing should be to the highest standard possible depending on the usage. For example, the 
artworks look especially beautiful on greeting cards printed on quality textured paper. However mass produc-
tion of posters for health posts would require a different quality of printing. 
•	 Use	the	illustrations	in	their	entirety—please	do	not	crop	or	otherwise	alter,	rotate	or	distort	them.
The Measles & Rubella Initiative Logo Specification
R:196 C:0 
G:20  M:100 
B:37 Y:90 
 K:20 
Red color specification
square height = x
Clear space to leave around logo
x
x
x x
Logotype with “disappearing dots”
Color
Black
Reverse
Reverse
with part
@ 50%
transparent
for effect
Color
Black
Reverse
Reverse
with dots
@ 50%
transparent
for effect
Logotype with strapline
MEASLES AND RUBELLA INITIATIVE BRANDING GUIDELINES 2013 / PAGE 14
ART ASSETS - SILHOUETTED PEOPLE ON WHITE BACKGROUNDS
Silhouette artwork can be placed on a colored background if needed, but works and looks best on a plain white 
background, or pale blue/pale green. Artwork must not be altered in any way. 
butterflynet800.REV.tif
FILENAME.TIF
Sweep800.REV.tif
FILENAME.TIF
FILENAME.TIF
EMROtrap800.tif
EMROsweep800.tif
chase800.REV.tifmeasles.mother&baby.REV.tif
Myanmar_Blackall.tif
EMROkite800.tif
EMROflick800.tif
EMROstomp800.tif
EMROchase800.tif
stomp800.REV.tif
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MeaslesandRubella.GraphicSilhouettes.eps
ART ASSETS - GRAPHIC SILHOUETTES OF CHILDREN
Graphic silhouette artwork can be used in places where more ‘universal’ representations of children are desired, 
or where something more subtle than full-color artwork is desired. Graphic silhouettes are based on the original 
artwork by Sophie Blackall and should not be altered in any way.
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ART ASSETS - FULL SCENE PAINTINGS 
Full scene paintings can be used in a variety of applications. Please do not place type over full-scene paintings. If 
type area is desired, created band of color on top or bottom of painting. 
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ART ASSETS - FULL SCENE PAINTINGS CONTINUED
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ART ASSETS - VACCINATION JOURNEY ILLUSTRATIONS
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ART ASSETS - VACCINATION JOURNEY ILLUSTRATIONS CONTINUED
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ART ASSETS - LET EVERY CHILD HAVE A NAME: THE ROAD TO A WORLD WITHOUT  
MEASLES  EXHIBIT
Banner designs were created for the Let Every Child Have a Name exhibit in 2012. Editable design layout files, and 
hi rez PDFs are available for reproduction. 
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EXAMPLES OF MEASLES AND RUBELLA INITIATIVE BRANDED DESIGNS
MEASLES MOVES FAST
WE MUST MOVE FASTER
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AEFI Adverse events following immunization 
AFR  WHO African Region
AMR WHO Region of the Americas
CDC  (United States) Centers for Disease Control and Prevention
CRS  Congenital rubella syndrome
EMTCT Eliminating mother-to-child transmission of HIV
EPI  Expanded programme on immunization
EMR  WHO Eastern Mediterranean Region
EUR  WHO European Region
GAVI The GAVI Alliance  
GVAP Global Vaccine Action Plan
IEC  International Expert Committee
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MCV Measles-containing vaccine
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MR  Measles-rubella vaccine
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PAHO Pan American Health Organization
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RED  Reaching every district
RI  Routine immunization
SAGE Strategic Advisory Group of Experts  
SEAR WHO South-East Asian Region
SIA  Supplementary immunization activity
TIV  Trivalent influenza vaccine
UNICEF United Nations Children’s Fund
WHO World Health Organization
WPR  WHO Western Pacific Region
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The year 2012 saw important gains in measles control. 
The Western Pacific Region, including China, reported 
a 93 per cent decline in measles cases between 2008 
and 2012, bringing the region to the verge of measles 
elimination. It was the year southern African countries 
brought their outbreaks under control through national 
campaigns. Cambodia used measles opportunities 
to identify children who were missed during routine 
immunization. It was also the year India, building on 
lessons and experience to stop transmission of polio, 
continued their drive to immunize 134 million children 
against measles in a phased campaign, followed by 
introduction of a second dose of measles vaccine in  
the routine system. 
Critically, 2012 was also the year 194 countries, through 
the resolution at the World Health Assembly adopting the 
Global Vaccine Action Plan, committed to the measles 
and rubella global and regional goals to reduce mortality 
and eliminate the disease. The Measles & Rubella 
Initiative provided a roadmap to do that, and for the first 
time released a new global strategic plan for measles 
and rubella, building on expert recommendations to 
include rubella vaccination and surveillance in measles 
activities. The GAVI Alliance pledged to help fund 
the plan, offering opportunities to introduce rubella-
containing vaccine to 49 countries, funds for measles 
campaigns in six of the most challenging countries,  
and funds to help stop measles outbreaks. 
With progress came challenges. More than 20 million 
infants did not receive measles or any other routine 
vaccines. While measles deaths have dropped by an 
astounding 71 per cent since 2000, an estimated 158,000 
children died of measles-related complications in 2011  
—about 430 child deaths a day, from a virus that can be 
countered with an effective, inexpensive vaccine.  
A large outbreak in the Democratic Republic of the Congo 
that flared to well over 130,000 cases in 2011 continued 
in 2012. Ukraine had the highest reported measles 
incidence in the world in 2012, one of several European 
countries that had outbreaks in 2011 and 2012, putting 
the goal of eliminating measles in Europe by 2015 at risk. 
Measles outbreaks in Afghanistan, Pakistan and Yemen, 
demonstrated how quickly measles travels and kills when 
routine immunization is weak. Several supplementary 
immunization campaigns—a strategic investment of 
time and money—failed to reach the goal of 95 per cent 
of children in every district. And about 103,000 children 
were born with congenital rubella syndrome, leaving 
many deaf and blind with heart and other conditions that 
poor families simply cannot afford to treat. 
The Initiative has prepared an annual report each year 
since 2001, but this report is different. For the first time, 
The Measles & Rubella Initiative is reporting progress 
in measles and rubella control against the five strategic 
priorities of the new Global Measles and Rubella Strategic 
Plan 2012-2020. The report exposes the strengths and 
weak points in the global effort to immunize every child 
against measles and rubella. These tell us how to focus 
efforts in 2013 and beyond, including a return to the 
basics of reaching all children with routine immunization. 
Measles and rubella move fast. We can—and must—now 
move faster. 
“With strong partnerships, 
resources and political will, we can, 
and must work together to achieve 
and maintain the elimination of 
measles, rubella and CRS globally”
— Heads of Agencies of the American Red Cross, 
US Centers for Disease Control and Prevention, 
the United Nations Foundation, 
UNICEF and World Health Organization
Executive  
summary
ART WORK AND DESIGN : 
The i l lustrations were produced by acclaimed il lustrator  
Sophie Blackall for The Measles & Rubella Init iat ive. 
Photograph on page 30 © UNICEF/NYHQ2012-1748; photograph 
on page 34 © UNICEF/NYHQ2012-2147; photograph on page 37 
© UNICEF/NYHQ2012-1631; photograph on page 40 © UNICEF/
NYHQ2012-2112. 
Photograph on page 13 is cour tesy of PAHO. 
Photograph on page 33 is cour tesy of Georgia Tech. 
All other photographs are cour tesy of C. McNab/The Measles & 
Rubella Init iat ive.
DISCL AIMER: The boundaries and names shown and the 
designations used on the maps in this document do not imply  
the expression of any opinion whatsoever on the par t of the 
World Health Organization concerning the legal status of any 
country, territory, cit y or area or of i ts authorit ies, or concerning 
the delimitation of i ts frontiers or boundaries. Dot ted l ines on  
maps represent approximate border l ines for which there may  
not yet be full agreement. © WHO 2013. All r ights reserved. 
This Annual Repor t was designed by Sara Gil l ingham Studio.
Summary of progress against indicators  
in the Strategic Plan 2012-2020
* This data will be available later in 2013   
** Data from countries that reported   
INDICATOR
2012 2011 2000
(# meeting indicator / # reporting and percentage)
Number and proportion of countries with measles  
incidence less than five cases per million population
* 104 / 188 = 55% 64 / 169 = 38%
Number and proportion of countries with coverage levels of first dose MCV and RCV >90% nationally and >80% in all districts
Number/proportion with MCV1 ≥90% * 123 / 194 = 63% 83/191 = 43%
Number/proportion with all districts having MCV1 ≥80% * 53 / 156 = 34% Not available
Number and proportion of countries conducting SIAs that year that  
achieve at least 95% coverage with M, MR or MMR in every district
3/18 = 17% **   3/23 = 13% ** Not available
Number of estimated measles deaths, the percentage reduction since 2000, and number of deaths averted through vaccination 
Estimated measles deaths * 158,000 548,000
Percentage reduction since 2000 * 71% Baseline
Cumulative number of deaths averted  
through measles vaccination since 2000
* 10,700,000 929,936
Number and proportion of measles-rubella priority countries providing  
funds to cover at least 50% of the operational cost of follow-up SIAs
21/32 = 66% 5/13 = 38% — 
Number and proportion of MCV and RCV SIAs  
that include additional child health interventions
26 / 32 = 81% 21 / 39 = 54% —
Number of new countries introducing RCV  
into their routine immunization programme
2 1 —
TABLE 1. Progress Indicators
INDICATOR
2012 2011 2000
(# meeting indicator / # reporting and percentage)
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Milestones 
By 2015
• Reduce annual measles incidence to less than five  
cases per million and maintain that level
• Exceed 90 per cent coverage with the first dose  
of measles-containing vaccine nationally and   
exceed 80 per cent vaccination coverage in every  
district or equivalent administrative unit
• Achieve at least 95 per cent coverage with   
measles vaccine, measles-rubella vaccine, or   
measles-mumps-rubella (MMR) vaccine during   
supplementary immunization activities (SIAs) in   
every district
• Establish a rubella/CRS elimination goal in at least  
three additional WHO regions 
• Establish a target date for the global eradication  
of measles
 
By 2020
• Sustain the achievement of the 2015 goals
• Achieve at least 95 per cent coverage with both  
first and second routine doses of measles or  
measles-rubella containing vaccines in each   
district and nationally
• Establish a target date for the global eradication  
of rubella and CRS
The plan also identifies key indicators against which to 
measure progress towards the milestones and goals. 
These are summarized in Table 1, and this Annual Report 
will look at these in more detail.
FIGURE 1. Measles and rubella control and elimination goals
The plan identifies 68 low and middle-income priority countries that have either not 
attained 90 per cent coverage with a first dose of measles-containing vaccine, or have 
not introduced rubella-containing vaccine into routine immunization programmes. 
The plan identifies the following milestones towards the regional and global goals: 
2000
2010
2015
—
2015
2015
2012
2015*
*WPR: rubella/CRS  
reduction by 2015
2020
—
SEAR: 95% 
measles 
mortality 
reduction by 
2015
Measles goals
Rubella goals
African Region
• Recorded an 84 per cent decline in measles 
mortality (2000 to 2011)—the most progress globally.
• 16 countries held measles campaigns reaching over 
47 million children.
• 42 per cent of countries recorded an incidence of 
less than 5 per million in 2012.
• 12 of 16 countries locally raised more than 50 per 
cent of the operational costs in 2012 campaigns.
• Three countries (Namibia, Niger and Zambia) 
conducted wide-age range campaigns to reach a 
growing older susceptible population.
• Large outbreaks continued in countries with weak 
underlying immunization systems (e.g., Angola, the 
Democratic Republic of the Congo and Ethiopia).
Americas Region
• Achieved and maintained measles elimination since 
2002 and rubella/CRS elimination since 2009.
• Successfully managed an outbreak in Ecuador 
caused by an importation. 
• Pockets of under-immunized populations remain 
at risk of virus importations, which result in costly 
outbreak response activities.
Eastern Mediterranean Region
• Thirteen of 23 countries (56 per cent) have measles 
incidence of less than 5 per million population. 
• Six countries held measles campaigns and reached 
more than 23 million children. 
• Three countries conducted wide-age range 
campaigns to reach a growing older susceptible 
population. 
• National measles elimination validation committees 
have been established in 10 countries. 
• Rapid political change in a number of countries is 
resulting in declines in immunization coverage. 
• A measles resurgence in Afghanistan, Pakistan, 
Somalia, the Sudan and Yemen due to weak routine 
immunization systems, delayed follow-up campaigns 
and low-quality SIAs.
• Measles epidemiological and molecular surveillance 
must be improved to a standard that supports 
validating measles elimination. 
European Region
• Established the Regional Verification Commission  
for Measles and Rubella Elimination. 
• Reported measles cases declined by 40 per cent 
compared with the previous year.
• Thirty-nine of 54 countries (74 per cent) recorded  
a measles incidence of less than 5 per million. 
•	 A few countries continued to experience persistent 
indigenous transmission and even widespread 
outbreaks (e.g., Romania, the Russian Federation, 
Spain and Ukraine).
•	 With more than 13,000 cases, Ukraine contributed  
to 56 per cent of the measles cases in Europe.  
The country suffered the politicization of 
immunization and failure to procure vaccines. 
• Rubella has been largely controlled in many 
countries; however, a few still reported a high 
incidence and outbreaks. 
•	 With more than 20,000 cases of rubella, Romania 
contributed to 74 per cent of cases in the region. 
•	 There are challenges with insufficient political 
commitment for measles elimination (in Western 
Europe) and health system reform (in Eastern 
Europe). 
•	 Vaccine hesitancy is a dominant issue in many 
countries. 
Regional Successes and Challenges
2012 global and 
regional highlights  
Global successes and challenges 
• More than 105 million children were vaccinated 
against measles in mass campaigns, of which 9.9 
million received the combined measles and rubella 
vaccine for the first time. 
• Global measles deaths were reduced by 71 per cent 
and measles incidence fell by 58 per cent (2000-2011). 
• First dose measles coverage reached 84 per cent of 
the global birth cohort). 
• The Western Pacific Region marked an 93 per cent 
decline in measles cases between 2008 and 2012, 
bringing the region to the verge of eliminating 
measles. 
• Elimination of measles, rubella and CRS was verified 
by the International Expert Committee in the 
Americas. 
• Eight additional countries introduced the second 
measles dose in their routine programme for a total 
of 146 of the WHO’s 194 Member States.  
• 21 of 32 countries M&RI supported to implement 
measles campaigns mobilized at least 50 per cent  
of the operational costs for the largest proportion 
of countries yet, demonstrating growing country 
ownership.
• For the first time, nine countries conducted wide-
age range national campaigns to stop their measles 
outbreaks affecting people over five years of age. 
• 26 of 32 countries M&RI supported to implement 
measles campaigns included one or more additional 
child health interventions, including Vitamin A, 
tetanus toxoid vaccine or deworming tables. 15 
included oral polio vaccination.
• 94 per cent of countries are using the recommended 
measles case-based surveillance and 98 per cent 
have access to standardized quality-controlled 
measles testing.
• Bangladesh and Nepal introduced rubella-containing 
vaccine. 
• The GAVI Alliance pledged more than US$700 million 
in support for measles and rubella activities.
And yet: 
•	 At least 20 million children did not receive a first 
measles vaccine dose before their first birthday. 
•	 About 430 children still die from measles each day, 
and more than 100,000 are born with congenital 
rubella syndrome every year.
•	 59 countries had not yet introduced rubella-
containing vaccines; 49 of them are GAVI-eligible.
•	 The Strategic Advisory Group of Experts determined 
that at the current pace, three regions (African, 
Eastern Mediterranean and European) are not  
on track to achieve their regional measles 
elimination goals. 
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MEASLES MOVES FAST
www.MeaslesRubella Init iat ive.org  @ MeaslesRubella 
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THE MEASLES AND RUBELLA INITIATIVE  
INFORMATION/CONTACTS
 
To learn more about the Measles & Rubella Initiative or to contact us: 
EMAIL: MeaslesRubellaInitiative@gmail.com 
WEBSITE: www.MeaslesRubellaInitiative.org 
THE BLOG: http://stopmeaslesrubella.org
TWITTER: @MeaslesRubella 
E-NEWSLETTER: http://bit.ly/ICQGJf 
THE STRATEGIC PLAN: http://bit.ly/IHKuCo  
IN IPAD FORMAT: http://bit.ly/meas-ru
THE 2012 ANNUAL REPORT: http://bit.ly/Z9yTTU
